Buspirone vs. Haloperidol: A Double-Blind Trial for Agitation in a Nursing Home Population With Alzheimer's Disease.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  The American journal of geriatric psychiatry

• Publication date

  1996-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/00019442-199622430-00011PMID 28531086
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Buspirone for myoclonus, obsessive fears, and confusion.

  1993cited by this paper
• Effects of Buspirone on Agitation Associated With Dementia.

  1993cited by this paper
• Treatment of aggression in juvenile-onset Huntington's disease with buspirone.

  1993cited by this paper
• Biologic Correlates of Suicidal Risk and Aggressive Behavioral Traits

  1992cited by this paper
• A pilot placebo-controlled study of chronic m-CPP administration in Alzheimer's disease.

  1991cited by this paper
• Nursing Home Resources and Tranquilizer Use among the Institutionalized Elderly

  1991cited by this paper
• Buspirone: A Worldwide Update

  1991cited by this paper
• The Prevalence and Management of Dementia and Other Psychiatric Disorders in Nursing Homes

  1990cited by this paper
• A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia

  1990cited by this paper
• Neuroleptics and alternative treatments. Management of behavioral symptoms and psychosis in Alzheimer's disease and related conditions.

  1988cited by this paper
• Psychosis, behavioral disturbance, and the use of neuroleptics in dementia.

  1988cited by this paper
• Neuroleptics in the treatment of dementia

  1988cited by this paper
• Buspirone and agitation in head injury.

  1988cited by this paper
• Buspirone in treatment of agitated demented patient.

  1988cited by this paper
• Treatment of Anxiety with Buspirone

  1987cited by this paper
• Agitated Behaviors in the Elderly: I. A Conceptual Review

  1986cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• The effect of buspirone on prolactin and growth hormone secretion in man.

  1983cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• A New Clinical Scale for the Staging of Dementia

  1982cited by this paper
• Efficacy of antipsychotic medications in behaviorally disturbed dementia patients.

  1982cited by this paper
• A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse.

  1980cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Letter: Mobile coronary care.

  1974cited by this paper
• The differentiation of anxiety and depressive disorders: a biometric approach.

  1971cited by this paper
• THE NURSES' OBSERVATION SCALE FOR INPATIENT EVALUATION: A NEW SCALE FOR MEASURING IMPROVEMENT IN CHRONIC SCHIZOPHRENIA.

  1965cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Clinical Effectiveness of Pharmacological and Non-Pharmacological Treatments for the Management of Anxiety in Community Dwelling People Living With Dementia: A Systematic Review and Meta-analysis.

  2023cites this paper
• 5-HT1A Partial Agonist Tandospirone for Behavioral and Psychological Symptoms in Oldest-old Patients with Dementia at a Special Elderly Nursing Home

  2021cites this paper
• Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates

  2020cites this paper
• Methylphenidate-Induced Raynaud Phenomenon Developed After Increasing Methylphenidate in an Adult With Attention-Deficit Hyperactivity Disorder.

  2019cites this paper
• Dose-Dependent Efficacy of Tandospirone for an Oldest-Old Patient With Behavioral and Psychological Symptoms of Dementia.

  2019cites this paper
• Buspirone for the treatment of dementia with behavioral disturbance

  2017cites this paper
• Buspirone: Back to the Future.

  2015cites this paper
• Managing anxiety associated with neurodegenerative disorders

  2015cites this paper
• Kampo therapy and behavioral and psychological symptoms of dementia

  2014cites this paper
• A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia.

  2014cites this paper
• Behavioral Neurology & Neuropsychiatry: Pharmacotherapy of emotional disturbances

  2013cites this paper
• Buspirone: what is it all about?

  2012cites this paper
• Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review

  2012cites this paper
• Representation of people with intellectual disabilities in randomised controlled trials on antipsychotic treatment for behavioural problems.

  2011cites this paper
• Behavioural Management in Alzheimer's Disease - Pharmacology

  2010cites this paper
• Use of Yi-Gan San (TJ-54) in patients with motor aphasia who refuse to participate in rehabilitation

  2010cites this paper
• A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.

  2009cites this paper
• Psychopharmacology for Neurologists

  2009cites this paper
• Psychopharmacology for neurologists.

  2009cites this paper
• ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia

  2008cites this paper
• A preliminary open-label study of 5-HT1A partial agonist tandospirone for behavioural and psychological symptoms associated with dementia.

  2007cites this paper
• Pharmacologic Management of Neuropsychiatric Symptoms of Alzheimer Disease

  2007cites this paper
• Clinical practice guidelines for severe Alzheimer's disease

  2007cites this paper
• The application of evidence-based principles of care in older persons (issue 5): Alzheimer's disease.

  2007cites this paper
• Efficacy of perospirone in the management of aggressive behavior associated with dementia.

  2006cites this paper
• Evidence-based interventions for nursing home residents with dementia-related behavioral symptoms.

  2005cites this paper
• The Pharmacological Approach of Behavioral Disturbances in Dementia

  2004cites this paper
• Management of Agitation in Individuals with Dementia: an Animal-assisted Therapy Approach

  2003cites this paper
• Buspirone in Alzheimer’s disease

  2003cites this paper
• Pharmacotherapy of dementia with Lewy bodies

  2003cites this paper
• Assessment and Treatment of Nursing Home Residents with Depression or Behavioral Symptoms Associated with Dementia: A Review of the Literature

  2003cites this paper
• Pharmacologic Management of Agitation in Alzheimer’s Disease

  2003cites this paper
• Central Serotonergic Activity is Related to the Aggressive Behaviors of Alzheimer's Disease

  2002cites this paper
• Haloperidol for agitation in dementia.

  2002cites this paper
• Pharmacological Treatment of Psychosis and Agitation in Elderly Patients with Dementia

  2002cites this paper
• Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: Time for a Different Paradigm?

  2001cites this paper
• Treating Psychotic Symptoms in Elderly Patients.

  2001cites this paper
• Recommendations for the Management of Behavioral and Psychological Symptoms of Dementia

  2001cites this paper
• Recognition and Management of Behavioral Disturbances in Dementia.

  2001cites this paper
• Pharmacologic therapy for behavioral symptoms of Alzheimer's disease.

  2001cites this paper
• Role of serotonin in the behavioral and psychological symptoms of dementia.

  2001cites this paper
• Assessment and management of behavioral disturbances in nursing home patients with dementia.

  2001cites this paper
• Alzheimer’s disease

  2000cites this paper
• A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias.

  2000cites this paper
• Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: characteristics and treatment.

  2000cites this paper
• [Treatment of agitation in dementia patients].

  1999cites this paper
• Buspirone: future directions.

  1999cites this paper
• Alzheimer’s Disease: Behavioral Management

  1999cites this paper
• Behavioral Disturbances of Dementia

  1998cites this paper
• Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.

  1998cites this paper
• Treatment of agitation in dementia.

  1997cites this paper
• Treatment of agitation in dementia.

  1997cites this paper
• From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia.

  1997cites this paper
• Buspirone

  1997cites this paper
• Treatment strategies for agitation and psychosis in dementia.

  1996cites this paper